Overview

Company Information

Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics and services some of the most prestigious medical institutions in the world. Our tests target cancers that are difficult to diagnose and predict treatment outcomes. These cancers include hematological, urogenital and HPV-associated cancers. We also offer a comprehensive range of non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. We have established strong research collaborations with major cancer centers such as Memorial Sloan-Kettering, The Cleveland Clinic, Mayo Clinic and the National Cancer Institute. For further information, please see www.cancergenetics.com.

Stock Information

Symbol
Market
Last
Change
Volume
As of

View Stock Information

Upcoming Events

Arizona Society of Pathologists

Nov 8 2014 • Phoenix, AZ

3rd Quarter 2014 Conference Call

Nov 10 2014

Dial-In Information
U.S. Toll-Free: 877-407-4018
International: 201-689-8471
Conference ID: 13594358

Replay Information
U.S. Toll-Free: 877-870-5176
International: 858-384-5517
Conference ID: 13594358
Available through November 24, 2014

Association for Molecular Pathology Annual Meeting

Nov 13 2014 - Nov 15 2014 • National Harbor, MD

Recent News

Contacts

Company

Cancer Genetics, Inc.
201 Route 17 North
2nd Floor
Rutherford, NJ 07070

Investor Relations

Life Science Advisors LLC
Michael Rice
646-597-6979